Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 267

1.

[Chronic B-lympho-proliferative disorders].

Varet B.

Presse Med. 2019 Jul - Aug;48(7-8 Pt 1):790-791. doi: 10.1016/j.lpm.2019.07.018. Epub 2019 Aug 19. French. No abstract available.

PMID:
31439444
2.

Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients.

Nicolini FE, Dulucq S, Boureau L, Cony-Makhoul P, Charbonnier A, Escoffre-Barbe M, Rigal-Huguet F, Coiteux V, Varet B, Dubruille V, Lenain P, Rousselot P, Rea D, Guerci-Bresler A, Legros L, Liu J, Gardembas M, Ianotto JC, Turlure P, Johnson-Ansah H, Martiniuc J, Jardel H, Joly B, Zunic P, Henni T, Villemagne B, Berger MG, Cayssials E, Guilhot F, Larosa F, Guilhot J, Etienne G, Mahon FX.

Clin Cancer Res. 2019 Nov 15;25(22):6606-6613. doi: 10.1158/1078-0432.CCR-18-3373. Epub 2019 Jul 10.

PMID:
31292142
3.

The SLC40A1 R178Q mutation is a recurrent cause of hemochromatosis and is associated with a novel pathogenic mechanism.

Ka C, Guellec J, Pepermans X, Kannengiesser C, Ged C, Wuyts W, Cassiman D, de Ledinghen V, Varet B, de Kerguenec C, Oudin C, Gourlaouen I, Lefebvre T, Férec C, Callebaut I, Le Gac G.

Haematologica. 2018 Nov;103(11):1796-1805. doi: 10.3324/haematol.2018.189845. Epub 2018 Jul 12.

4.

Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia.

Legros L, Nicolini FE, Etienne G, Rousselot P, Rea D, Giraudier S, Guerci-Bresler A, Huguet F, Gardembas M, Escoffre M, Ianotto JC, Noël MP, Varet BR, Pagliardini T, Touitou I, Morisset S, Mahon FX; French Intergroup for Chronic Myeloid Leukemias.

Cancer. 2017 Nov 15;123(22):4403-4410. doi: 10.1002/cncr.30885. Epub 2017 Jul 25.

5.

Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia.

Etienne G, Guilhot J, Rea D, Rigal-Huguet F, Nicolini F, Charbonnier A, Guerci-Bresler A, Legros L, Varet B, Gardembas M, Dubruille V, Tulliez M, Noel MP, Ianotto JC, Villemagne B, Carré M, Guilhot F, Rousselot P, Mahon FX.

J Clin Oncol. 2017 Jan 20;35(3):298-305. doi: 10.1200/JCO.2016.68.2914. Epub 2016 Oct 31.

PMID:
28095277
6.

Severe chronic primary neutropenia in adults: report on a series of 108 patients.

Sicre de Fontbrune F, Moignet A, Beaupain B, Suarez F, Galicier L, Socié G, Varet B, Coppo P, Michel M, Pautas C, Oksenhendler E, Lengline E, Terriou L, Moreau P, Chantepie S, Casadevall N, Michot JM, Gardembas M, Michallet M, Croisille L, Audrain M, Bellanné-Chantelot C, Donadieu J, Lamy T; French Severe Chronic Neutropenia Registry.

Blood. 2015 Oct 1;126(14):1643-50. doi: 10.1182/blood-2015-03-634493. Epub 2015 Aug 10.

PMID:
26261239
7.

Reply to J. Richter et al.

Rousselot P, Charbonnier A, Cony-Makhoul P, Agape P, Nicolini FE, Varet B, Gardembas M, Etienne G, Réa D, Roy L, Escoffre-Barbe M, Guerci-Bresler A, Tulliez M, Prost S, Spentchian M, Cayuela JM, Reiffers J, Chomel JC, Turhan A, Guilhot J, Guilhot F, Mahon FX.

J Clin Oncol. 2014 Sep 1;32(25):2823-5. doi: 10.1200/JCO.2014.56.3858. Epub 2014 Jul 28. No abstract available.

PMID:
25071119
8.

Peripheral blood 8 colour flow cytometry monitoring of hairy cell leukaemia allows detection of high-risk patients.

Garnache Ottou F, Chandesris MO, Lhermitte L, Callens C, Beldjord K, Garrido M, Bedin AS, Brouzes C, Villemant S, Rubio MT, Belanger C, Suarez F, Deau B, Lefrère F, Hermine O, Asnafi V, Varet B, Macintyre E.

Br J Haematol. 2014 Jul;166(1):50-9. doi: 10.1111/bjh.12839. Epub 2014 Mar 25.

PMID:
24661013
9.

Autoimmune neutropenia after kidney transplantation: a disregarded entity of posttransplant neutropenia.

Aubert O, Sberro-Soussan R, Scemla A, Casadevall N, Teyssandier I, Martinez F, Hermine O, Legendre C, Varet B, De Fontbrune FS.

Transplantation. 2014 Apr 15;97(7):725-9. doi: 10.1097/TP.0000000000000109.

PMID:
24598937
10.

BRAF(V600E) mutation in a histiocytic sarcoma arising from hairy cell leukemia.

Michonneau D, Kaltenbach S, Derrieux C, Trinquand A, Brouzes C, Gibault L, North MO, Delarue R, Varet B, Emile JF, Brousse N, Hermine O.

J Clin Oncol. 2014 Dec 10;32(35):e117-21. doi: 10.1200/JCO.2013.49.0078. Epub 2014 Feb 24. No abstract available.

PMID:
24567436
11.

Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease.

Rousselot P, Charbonnier A, Cony-Makhoul P, Agape P, Nicolini FE, Varet B, Gardembas M, Etienne G, Réa D, Roy L, Escoffre-Barbe M, Guerci-Bresler A, Tulliez M, Prost S, Spentchian M, Cayuela JM, Reiffers J, Chomel JC, Turhan A, Guilhot J, Guilhot F, Mahon FX.

J Clin Oncol. 2014 Feb 10;32(5):424-30. doi: 10.1200/JCO.2012.48.5797. Epub 2013 Dec 9.

PMID:
24323036
12.

Update on transcobalamin deficiency: clinical presentation, treatment and outcome.

Trakadis YJ, Alfares A, Bodamer OA, Buyukavci M, Christodoulou J, Connor P, Glamuzina E, Gonzalez-Fernandez F, Bibi H, Echenne B, Manoli I, Mitchell J, Nordwall M, Prasad C, Scaglia F, Schiff M, Schrewe B, Touati G, Tchan MC, Varet B, Venditti CP, Zafeiriou D, Rupar CA, Rosenblatt DS, Watkins D, Braverman N.

J Inherit Metab Dis. 2014 May;37(3):461-73. doi: 10.1007/s10545-013-9664-5. Epub 2013 Dec 5.

PMID:
24305960
13.

Immune aregenerative anemia without erythroblastopenia: a previously undescribed condition.

Brousse V, Brouzes C, Sicre de Fontbrune F, Casadevall N, Varet B.

Ann Hematol. 2013 Sep;92(9):1289-90. doi: 10.1007/s00277-013-1696-2. Epub 2013 Feb 14. No abstract available.

PMID:
23408098
14.

[How to differentiate between useful and useless drugs?].

Bergmann JF, Thervet E, Timsit J, Blacher J, Varet B, Hartemann A, Chosidow O, Mariette X, Gervais A, Amoura Z, Bruckert E, Pariente A, Vernant JP, Penformis F, Dautzenberg B, Sobel A, Guillevin L, Valla D, Leblond V, Gaudric A, Chast F, Bourdillon F, Fredenrich A, Bourgeois P, Grimaldi A.

Rev Prat. 2012 Nov;62(9):1192-5. French. No abstract available.

PMID:
23272464
15.

[Letter on the article: "the pseudo-thrombotic microangiopathy: a diagnostic pitfall"].

Varet B.

Presse Med. 2013 Jan;42(1):122. doi: 10.1016/j.lpm.2012.08.002. Epub 2012 Oct 15. French. No abstract available.

PMID:
23079389
16.

Bing and neel syndrome.

Jennane S, Doghmi K, Mahtat EM, Messaoudi N, Varet B, Mikdame M.

Case Rep Hematol. 2012;2012:845091. doi: 10.1155/2012/845091. Epub 2012 Aug 26.

17.

Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival.

Rubio MT, Moreira-Teixeira L, Bachy E, Bouillié M, Milpied P, Coman T, Suarez F, Marcais A, Sibon D, Buzyn A, Caillat-Zucman S, Cavazzana-Calvo M, Varet B, Dy M, Hermine O, Leite-de-Moraes M.

Blood. 2012 Sep 6;120(10):2144-54. doi: 10.1182/blood-2012-01-404673. Epub 2012 Jun 22.

PMID:
22730537
18.

Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma.

Deau B, Bachy E, Ribrag V, Delarue R, Rubio MT, Bosq J, Varet B, Brousse N, Hermine O, Canioni D.

Leuk Lymphoma. 2013 Jan;54(1):41-5. doi: 10.3109/10428194.2012.698274. Epub 2012 Jul 9.

PMID:
22667341
19.

Concomitant lupus anticoagulant and monoclonal IgMκ antibody in a patient with bleeding tendency: a case report and literature review.

Alyanakian MA, Okada H, Bachelot-Loza C, Tournoux P, Varet B, Lasne D.

Am J Hematol. 2011 Oct;86(10):868-71. No abstract available.

20.

[Criteria for suspecting a myelodysplastic syndrome].

Varet B, Ifrah N.

Rev Prat. 2010 Dec 20;60(10):1404-7. French.

PMID:
21425539
21.

Caspase-activated ROCK-1 allows erythroblast terminal maturation independently of cytokine-induced Rho signaling.

Gabet AS, Coulon S, Fricot A, Vandekerckhove J, Chang Y, Ribeil JA, Lordier L, Zermati Y, Asnafi V, Belaid Z, Debili N, Vainchenker W, Varet B, Hermine O, Courtois G.

Cell Death Differ. 2011 Apr;18(4):678-89. doi: 10.1038/cdd.2010.140. Epub 2010 Nov 12.

22.

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial.

Mahon FX, Réa D, Guilhot J, Guilhot F, Huguet F, Nicolini F, Legros L, Charbonnier A, Guerci A, Varet B, Etienne G, Reiffers J, Rousselot P; Intergroupe Français des Leucémies Myéloïdes Chroniques.

Lancet Oncol. 2010 Nov;11(11):1029-35. doi: 10.1016/S1470-2045(10)70233-3. Epub 2010 Oct 19.

PMID:
20965785
23.

Anorectal Epstein-Barr virus infection mimicking Hodgkin lymphoma in an immunocompetent man.

Vasiliu V, Suarez F, Canioni D, Hermine O, Varet B, Brousse N.

Am J Surg Pathol. 2010 Nov;34(11):1715-9. doi: 10.1097/PAS.0b013e3181eded23.

PMID:
20861713
24.

[Weight loss and fever in a 72-year-old man].

Arlet JB, Varet B, Hermine O, Capron L, Pouchot J, Chiche L.

Rev Med Interne. 2010 Jun;31(6):453-7. doi: 10.1016/j.revmed.2010.02.002. Epub 2010 Mar 27. French. No abstract available.

PMID:
20347510
25.

[Long-term efficacy of autologous stem cell transplantation for stage IV mycosis fungoides].

Di Lucca-Chrisment J, Maubec E, Grossin M, Marinho E, Varet B, Maillard H, Crickx B.

Ann Dermatol Venereol. 2009 Nov;136(11):800-5. doi: 10.1016/j.annder.2009.04.017. Epub 2009 Jul 25. French.

PMID:
19917433
26.

Rapamycin for refractory acute graft-versus-host disease.

Ghez D, Rubio MT, Maillard N, Suarez F, Chandesris MO, Delarue R, Deau-Fischer B, Varet B, Hermine O, Buzyn A.

Transplantation. 2009 Nov 15;88(9):1081-7. doi: 10.1097/TP.0b013e3181ba0a13.

PMID:
19898203
27.

Tax unleashed: fulminant Tax-positive Adult T-cell Leukemia/Lymphoma after failed allogeneic stem cell transplantation.

Ghez D, Renand A, Lepelletier Y, Sibon D, Suarez F, Rubio MT, Delarue R, Buzyn A, Beljord K, Tanaka Y, Varet B, Hermine O.

J Clin Virol. 2009 Dec;46(4):378-80. doi: 10.1016/j.jcv.2009.07.020.

PMID:
19836302
28.

[High risk of cardiac dysfunction after treatment of secondary acute myeloid leukemia following chemotherapy and radiotherapy for breast cancer].

Willems L, Suarez F, Messas E, Baubion N, Decaudin D, Fourquet A, Ghez D, Delarue R, Hermine O, Buzyn A, Varet B, Rubio MT.

Bull Cancer. 2010 Feb;97(2):245-54. doi: 10.1684/bdc.2009.0958. French.

29.

Prognostic significance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: a study of 59 cases.

Canioni D, Deau-Fischer B, Taupin P, Ribrag V, Delarue R, Bosq J, Rubio MT, Roux D, Vasiliu V, Varet B, Brousse N, Hermine O.

PLoS One. 2009 Jul 22;4(7):e6341. doi: 10.1371/journal.pone.0006341.

30.

LRRFIP1, a new FGFR1 partner gene associated with 8p11 myeloproliferative syndrome.

Soler G, Nusbaum S, Varet B, Macintyre EA, Vekemans M, Romana SP, Radford-Weiss I.

Leukemia. 2009 Jul;23(7):1359-61. doi: 10.1038/leu.2009.79. Epub 2009 Apr 16. No abstract available.

PMID:
19369959
31.

High risk of cardiac dysfunction after treatment of secondary acute myeloid leukaemia to breast cancer.

Willems L, Suarez F, Baubion N, Decaudin D, Ghez D, Hermine O, Varet B, Rubio MT.

Ann Oncol. 2009 Mar;20(3):597-9. doi: 10.1093/annonc/mdn776. Epub 2009 Jan 27. No abstract available.

32.

Complete remission of a relapsing adult T cell leukaemia following treatment of a secondary acute promyelocytic leukaemia: towards a reappraisal of arsenic trioxide and all-transretinoic acid?

Chandesris MO, Ghez D, Besson C, Suarez F, Delarue R, Rubio MT, Bazarbachi A, Varet B, Hermine O.

BMJ Case Rep. 2009;2009. pii: bcr01.2009.1449. doi: 10.1136/bcr.01.2009.1449. Epub 2009 Aug 10.

33.

Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance.

Suarez F, Lortholary O, Buland S, Rubio MT, Ghez D, Mahé V, Quesne G, Poirée S, Buzyn A, Varet B, Berche P, Bougnoux ME.

J Clin Microbiol. 2008 Nov;46(11):3772-7. doi: 10.1128/JCM.01086-08. Epub 2008 Sep 24.

34.

Immune-mediated pure red cell aplasia in renal transplant recipients.

Zuber J, Beldjord K, Casadevall N, Thervet E, Legendre C, Varet B.

Haematologica. 2008 Nov;93(11):1750-2. doi: 10.3324/haematol.13477. Epub 2008 Sep 11. No abstract available.

35.

[Role of erythropoietins for anemia in hematologic oncology].

Delarue R, Varet B.

Presse Med. 2008 Sep;37(9):1334-41. doi: 10.1016/j.lpm.2007.08.023. Epub 2008 Aug 9. Review. French.

PMID:
18692984
36.

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study.

Godeau B, Porcher R, Fain O, Lefrère F, Fenaux P, Cheze S, Vekhoff A, Chauveheid MP, Stirnemann J, Galicier L, Bourgeois E, Haiat S, Varet B, Leporrier M, Papo T, Khellaf M, Michel M, Bierling P.

Blood. 2008 Aug 15;112(4):999-1004. doi: 10.1182/blood-2008-01-131029. Epub 2008 May 7.

PMID:
18463354
37.

The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells.

Mamani-Matsuda M, Cosma A, Weller S, Faili A, Staib C, Garçon L, Hermine O, Beyne-Rauzy O, Fieschi C, Pers JO, Arakelyan N, Varet B, Sauvanet A, Berger A, Paye F, Andrieu JM, Michel M, Godeau B, Buffet P, Reynaud CA, Weill JC.

Blood. 2008 May 1;111(9):4653-9. doi: 10.1182/blood-2007-11-123844. Epub 2008 Mar 3.

38.

Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis.

Lefrère F, Zohar S, Beaudier S, Audat F, Ribeil JA, Ghez D, Varet B, Cavazzana-Calvo M, Dal Cortivo L, Letestu R, McIntyre E, Brouzes C.

Transfusion. 2007 Oct;47(10):1851-7.

PMID:
17880611
39.

Diffuse large B-cell lymphoma in hyperimmunoglobulinemia E syndrome.

Wallet N, Ghez D, Delarue R, Suarez F, Rubio MT, Fischer A, Canioni D, Varet B, Hermine O.

Clin Lymphoma Myeloma. 2007 May;7(6):425-7.

PMID:
17621409
40.

Coexistence and parallel evolution of hypereosinophilic syndrome, autoimmune hepatitis, and ulcerative colitis suggest common pathogenic features.

Terrier B, Fontaine H, Schmitz J, Perdu J, Hermine O, Varet B, Buzyn A, Suarez F.

Am J Gastroenterol. 2007 May;102(5):1132-4. No abstract available.

PMID:
17489793
41.

Dramatic clinical efficacy of cladribine in Rosai-Dorfman disease and evolution of the cytokine profile: towards a new therapeutic approach.

Aouba A, Terrier B, Vasiliu V, Candon S, Brousse N, Varet B, Hermine O.

Haematologica. 2006 Dec;91(12 Suppl):ECR52.

42.

Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1.

Ribeil JA, Zermati Y, Vandekerckhove J, Cathelin S, Kersual J, Dussiot M, Coulon S, Moura IC, Zeuner A, Kirkegaard-Sørensen T, Varet B, Solary E, Garrido C, Hermine O.

Nature. 2007 Jan 4;445(7123):102-5. Epub 2006 Dec 10.

PMID:
17167422
43.

Autoimmune manifestations in acquired idiopathic splenic atrophy: A puzzling association.

Coppo P, Saadoun D, Varet B.

Eur J Intern Med. 2006 Dec;17(8):580-2.

PMID:
17142180
44.

High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group.

Taksin AL, Legrand O, Raffoux E, de Revel T, Thomas X, Contentin N, Bouabdallah R, Pautas C, Turlure P, Reman O, Gardin C, Varet B, de Botton S, Pousset F, Farhat H, Chevret S, Dombret H, Castaigne S.

Leukemia. 2007 Jan;21(1):66-71. Epub 2006 Oct 19.

PMID:
17051246
45.

Monoclonal immunoglobulin with antitransferrin activity: A rare cause of hypersideremia with increased transferrin saturation.

Alyanakian MA, Taes Y, Bensaïd M, Segovia B, Aucouturier P, Rain JD, Delanghe J, Varet B, Beaumont C.

Blood. 2007 Jan 1;109(1):359-61. Epub 2006 Sep 12.

PMID:
16968894
46.

Fas ligand-mediated lethal hepatitis after rapid lysis of a localized natural killer cell lymphoma.

Ghez D, Damotte D, Perrine SP, Faller DV, Canioni D, Brousse N, Lefrère F, Varet B, Hermine O.

Clin Lymphoma Myeloma. 2006 Mar;6(5):417-9.

PMID:
16640822
47.

A double-blind low dose-finding phase II study of granulocyte colony-stimulating factor combined with chemotherapy for stem cell mobilization in patients with non-Hodgkin's lymphoma.

Lefrère F, Zohar S, Bresson JL, Chevret S, Mogenet A, Audat F, Durand-Zaleski I, Ghez D, Dal Cortivo L, Piesvaux P, Cavazzana-Calvo M, Varet B.

Haematologica. 2006 Apr;91(4):550-3.

48.

[Monoclonal gammopathies: which reasoning to adopt?].

Varet B.

Rev Prat. 2006 Jan 15;56(1):15-7. Review. French. No abstract available.

PMID:
16548244
49.

Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia.

Asnafi V, Rubio MT, Delabesse E, Villar E, Davi F, Damaj G, Hirsch I, Dhédin N, Vernant JP, Varet B, Buzyn A, Macintyre E.

Leukemia. 2006 May;20(5):793-9.

PMID:
16541140
50.

High-risk pregnancies in Diamond-Blackfan anemia: a survey of 64 pregnancies from the French and German registries.

Faivre L, Meerpohl J, Da Costa L, Marie I, Nouvel C, Gnekow A, Bender-Götze C, Bauters F, Coiffier B, Peaud PY, Rispal P, Berrebi A, Berger C, Flesch M, Sagot P, Varet B, Niemeyer C, Tchernia G, Leblanc T.

Haematologica. 2006 Apr;91(4):530-3. Epub 2006 Mar 15.

Supplemental Content

Support Center